跳至主要内容
临床试验/NCT03064165
NCT03064165已完成4 期

Postoperative Analgesia After Elective Hip Surgery - Effect of Obturator

University of Aarhus1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2017年8月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
62
试验地点
1
主要终点
Opioid dose 0-12 hour after total hip replacement

研究概览

简要总结

The study investigates the effect of an obturator nerve block on the postoperative pain and opioid consumption after total hip replacement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients for primary hip replacement in spinal anesthesia
  • Age >= 18 years
  • American Society of Anesthesiologists physical status classification score I-III
  • Informed consent

排除标准

  • Lacking the ability to corporate
  • Lacking the ability to speak danish
  • Planned discharge on the same day of surgery
  • Neuropathy of the lower extremities
  • Contraindications for NonSteroidal Anti-Inflammatory Drugs (NSAID)
  • Contraindications for dexamethasone
  • Chronic opioid demanding pain
  • Pregnancy
  • Allergy towards one or both investigatory medicinal products
  • Active treatment with amiodarone
  • Active treatment with verapamil
  • Active treatment with corticosteroids

研究组 & 干预措施

Obturator nerve block

Experimental

Postoperative obturator nerve block with 15 mL bupivacain 5 mg/mL and epinephrine 5 µg/mL.

干预措施: Bupivacaine-epinephrine (Drug)

Obturator nerve block

Experimental

Postoperative obturator nerve block with 15 mL bupivacain 5 mg/mL and epinephrine 5 µg/mL.

干预措施: Obturator nerve block (Procedure)

Sham block

Placebo Comparator

Postoperative sham-block with normal saline.

干预措施: Sham block (Procedure)

Sham block

Placebo Comparator

Postoperative sham-block with normal saline.

干预措施: Sodium Chloride 9mg/mL (Drug)

结局指标

主要结局

Opioid dose 0-12 hour after total hip replacement

时间窗: 0-12 hour after completion of total hip replacement

Cumulated dose of opioid 0-12 hour after total hip replacement

次要结局

  • Incidences of emesis 0-18 hours after total hip replacement.(0-18 hours after completion of total hip replacement)
  • Cumulated dose of ondansetron 0-18 hours after total hip replacement(0-18 hours after completion of total hip replacement)
  • Cumulated dose of droperidol 0-18 hours after total hip replacement(0-18 hours after completion of total hip replacement)
  • Length of stay on post anesthesia care unit after completion of total hip replacement(24 hours after completion of total hip replacement)
  • Length of stay on hospital after completion of total hip replacement(Up to 2 days)
  • Ability to ambulate 5 hours after surgery(5 hours after completion of total hip replacement)
  • Motor control with operated leg(5 hours after completion of total hip replacement)
  • Cumulated dose of opioid 12-18 hours after total hip replacement.(12-18 hours after completion of total hip replacement)
  • Pain at rest at time of examination (numeric rating scale)(1, 2, 5, 7 and 24 hours after completion of total hip replacement)
  • Pain at passive 90-degree hip flexion (numeric rating scale)(1, 2, 5, 7 and 24 hours after completion of total hip replacement)
  • Worst pain during ambulation on the day of surgery(5 hours after completion of total hip replacement)
  • Time from completion of surgery to first dose of opioid(24 hours after completion of total hip replacement)
  • Intensity of nausea on time of examination (numeric rating scale)(1, 2, 5, 7 and 24 hours after completion of total hip replacement)
  • Duration of spinal anesthesia(0-4 hours after completion of total hip replacement)
  • Self-reported sleep quality the first night after total hip replacement(24 hours after completion of total hip replacement)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Niels Dalsgaard Nielsen

MD, PhD-fellow

University of Aarhus

研究点 (1)

Loading locations...

相似试验